乡村医生主导的远程医疗用于农村75岁及以上房颤患者:MIRACLE-AF试验预设二次分析
该研究为MIRACLE-AF整群随机临床试验的预设亚组分析,在江苏省江都县30家村卫生室开展,纳入≥75岁农村房颤患者589例(干预组297例、常规照护组292例),随访36个月。乡村医生主导、远程医疗支持的整合房颤照护模式使主要复合终点(心血管死亡、缺血性或出血性卒中、心衰恶化或急性冠脉综合征住院、房颤急诊就诊)年发生率显著低于常规照护(7.4% vs 11.3%,率差-3.93个百分点,aHR 0.70,95%CI 0.49-0.98,P=0.04)。作者结论认为该新模式显著改善了≥75岁农村房颤患者的结局。
要点
- ≥75岁农村房颤患者中,干预组主要复合终点年发生率为7.4%(95%CI 5.6%-9.2%),常规照护组为11.3%(95%CI 8.5%-14.1%)。
- 率差为-3.93个百分点(95%CI -7.41至-0.44,P=0.02),校正后HR为0.70(95%CI 0.49-0.98,P=0.04)。
- 干预模式为乡村医生主导、远程医疗支持的整合房颤照护,对照为常规照护,随访36个月。
- 本研究为MIRACLE-AF整群随机临床试验的预设亚组分析,共纳入≥75岁患者589例(干预组297例、常规照护组292例)。
- 研究在江苏省江都县30家村卫生室开展,纳入标准为≥65岁农村房颤患者,本分析限定≥75岁。
适用人群与场景
- MIRACLE-AF试验纳入标准:年龄≥65岁、居住在研究覆盖农村村庄的房颤患者;本预设亚组分析限定年龄≥75岁者。
- 本分析共纳入589例≥75岁房颤患者(中位年龄79岁,IQR 77-82岁;女性273例,46.3%),干预组297例、常规照护组292例。
- 研究场景为江苏省江都县30家村卫生室,干预由乡村医生主导并接受远程医疗支持。
处置流程与药物剂量
- 干预组接受乡村医生主导、远程医疗支持的整合房颤照护模式;对照组接受常规照护。
研究设计与关键结果
- 研究类型:MIRACLE-AF整群随机临床试验的预设亚组分析,在30家村卫生室开展,纳入≥75岁房颤患者589例(干预组297例、常规照护组292例),随访36个月。
- 主要复合终点(心血管死亡、缺血性或出血性卒中、心衰恶化或急性冠脉综合征住院、房颤急诊就诊)年发生率:干预组7.4%(95%CI 5.6%-9.2%)vs 常规照护组11.3%(95%CI 8.5%-14.1%),率差-3.93个百分点(95%CI -7.41至-0.44,P=0.02),校正后HR 0.70(95%CI 0.49-0.98,P=0.04)。
- MIRACLE-AF试验主分析共纳入1039例患者(平均年龄75.8岁,SD 5.7岁;女性460例,44.3%)。
- 作者结论:该新模式显著改善了≥75岁农村房颤患者的结局。
证据类型、等级与局限
- 证据类型:整群随机临床试验的预设亚组分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于≥75岁农村房颤患者,乡村医生主导、远程医疗支持的整合照护模式在该试验中显著降低了主要复合终点风险(aHR 0.70,95%CI 0.49-0.98)。
- 该干预模式由乡村医生主导并接受远程医疗支持,适用于农村村卫生室场景下的≥75岁房颤患者。
指南或共识出处
- MIRACLE-AF试验(Novel Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural China),ClinicalTrials.gov注册号NCT04622514。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Delivering integrated atrial fibrillation (AF) care to rural patients remains challenging. Patients aged 75 years and older in rural areas represent a particularly at-risk subgroup, and effective and scalable strategies to optimize AF care in this population are urgently needed.
OBJECTIVE: To evaluate the effectiveness of a village doctor-led, telemedicine-supported integrated care model in rural patients aged 75 years and older with AF.
DESIGN, SETTING, AND PARTICIPANTS: This was a prespecified subgroup analysis of the Novel Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural China (MIRACLE-AF) cluster randomized clinical trial, which was conducted across 30 village clinics in Jiangdu County, Jiangsu Province, China, from December 2020 to May 2024. Patients with AF aged 65 years and older and residing in rural villages under study were eligible for the MIRACLE-AF trial. In this prespecified subgroup study, patients aged 75 years and older were analyzed. Additional age cutoffs (≥70, ≥75, and ≥80 years) were applied to assess the consistency of intervention benefits across age groups.
INTERVENTIONS: Village doctor-led, telemedicine-supported integrated AF care or usual care.
MAIN OUTCOMES AND MEASURES: A composite of cardiovascular death, ischemic or hemorrhagic stroke, hospitalization for worsening heart failure or acute coronary syndrome, and emergency visits for AF.
RESULTS: Among 1039 patients included in the primary analysis of the MIRACLE-AF trial (mean [SD] age, 75.8 [5.7] years; 460 women [44.3%]), 589 patients with AF aged 75 years or older (median [IQR] age, 79 [77-82] years; 273 women [46.3%]) were included in this analysis. Among them, 297 patients received the MIRACLE-AF intervention and 292 patients received usual care. Over 36 months of follow-up, the MIRACLE-AF intervention resulted in a significantly lower risk of the primary composite outcome compared with usual care (7.4%; 95% CI, 5.6%-9.2% vs 11.3%; 95% CI, 8.5%-14.1% per year; rate difference, -3.93 percentage points; 95% CI, -7.41 to -0.44 percentage points; P = .02; adjusted hazard ratio, 0.70; 95% CI, 0.49 to 0.98; P = .04).
CONCLUSIONS AND RELEVANCE: In this prespecified subgroup analysis of the MIRACLE-AF trial, a novel care model significantly improved outcomes in patients with AF aged 75 years or older in rural settings.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04622514.
参考来源
- Li M, Chen Y, Chu M, et al. Village Doctor-Led Telemedicine for Rural Patients Aged 75 Years and Older With AF: A Prespecified Secondary Analysis of the MIRACLE-AF Trial. JAMA Netw Open. 2026. PMID: 41817526. doi:10.1001/jamanetworkopen.2026.1385
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。